Ventas
About: Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Employees: 486
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
50% more funds holding in top 10
Funds holding in top 10: 10 [Q2] → 15 (+5) [Q3]
32% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 72
28% more call options, than puts
Call options by funds: $58.7M | Put options by funds: $46M
26% more capital invested
Capital invested by funds: $20B [Q2] → $25.2B (+$5.18B) [Q3]
25% more repeat investments, than reductions
Existing positions increased: 284 | Existing positions reduced: 227
3% more funds holding
Funds holding: 685 [Q2] → 708 (+23) [Q3]
1.82% less ownership
Funds ownership: 96.68% [Q2] → 94.86% (-1.82%) [Q3]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$65
11%
upside
Avg. target
$68
15%
upside
High target
$71
21%
upside
4 analyst ratings
2 positive
50%
2 neutral
50%
0 negative
0%
Baird David Rodgers 48% 1-year accuracy 10 / 21 met price target | 12%upside $66 | Neutral Maintained | 20 Dec 2024 |
Mizuho Vikram Malhorta 64% 1-year accuracy 14 / 22 met price target | 16%upside $68 | Outperform Maintained | 5 Dec 2024 |
Scotiabank Nicholas Yulico 43% 1-year accuracy 15 / 35 met price target | 11%upside $65 | Sector Perform Maintained | 11 Oct 2024 |
Wells Fargo John Kilichowski 0% 1-year accuracy 0 / 5 met price target | 21%upside $71 | Overweight Assumed | 1 Oct 2024 |
Financial journalist opinion
Based on 6 articles about VTR published over the past 30 days
Positive
Zacks Investment Research
21 hours ago
Ventas Reaches Mutually Beneficial Agreements With Brookdale
Agreements with Brookdale Senior Living highlight VTR's strategy to drive profitable growth in the senior housing business.
Neutral
Zacks Investment Research
1 day ago
Here's Why You Should Retain Ventas Stock in Your Portfolio Now
Rising healthcare spending and aging population aid VTR's senior housing operating portfolio. However, competitive market and tenant concentration remain risks.
Neutral
Business Wire
2 days ago
Ventas Reaches Mutually Beneficial Agreements with Brookdale Senior Living
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that it has reached mutually beneficial agreements with Brookdale Senior Living (“Brookdale”) regarding all assets under the current Master Lease (the “Master Lease”) between Ventas and Brookdale. The agreements provide a comprehensive, clear outcome for Ventas as it executes its strategy to drive profitable growth in its senior housing business. The Master Lease was previously set to expire on Decemb.
Neutral
Business Wire
1 week ago
Ventas Declares Fourth Quarter 2024 Dividend of $0.45 Per Common Share
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on January 16, 2025 to stockholders of record as of the close of business on December 31, 2024. About Ventas Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With.
Neutral
Zacks Investment Research
2 weeks ago
Ventas' Tenant Brookdale Opts Out to Exercise Lease Extension
Brookdale Senior Living, a tenant of VTR, chooses not to exercise the extension term of Master Lease.
Neutral
Business Wire
2 weeks ago
Ventas Comments on Master Lease with Brookdale Senior Living
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that Brookdale Senior Living (“Brookdale”) did not exercise its right to extend the term of the Master Lease between the companies (the “Master Lease”) for a renewal term commencing January 1, 2026. Thus, Brookdale no longer has a right to extend the lease term for any assets currently covered by the Master Lease. The Company intends to deploy its Ventas OITM platform and successful playbook to conver.
Neutral
Business Wire
1 month ago
Ventas Earns Nareit 2024 Healthcare “Leader in the Light” Award
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that it has earned the 2024 Nareit “Leader in the Light” award for the Healthcare sector in recognition of its superior and longstanding sustainability practices. This is the eighth time Ventas has received this important recognition. In addition, Ventas was recognized with Nareit's inaugural “Impact at Scale” award for the Company's innovative and scalable approach to decarbonization. As part of its commitment to achieving net.
Neutral
Business Wire
1 month ago
Ventas to Participate in Investor Meetings at Nareit's REITworld 2024 Annual Conference
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at Nareit's REITworld 2024 Annual Conference (the “Nareit Conference”) on November 18-19, 2024. Any new or updated written materials that the Company expects to use in connection with its participation at the Nareit Conference will be made available on the Company's website on or prior to the morning of November 18, 2024. Any such materials will be.
Neutral
Business Wire
1 month ago
Ventas Announces Pricing of an Underwritten Offering of 10.6 Million Shares of Common Stock
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it priced an underwritten public offering of 10,600,000 shares of its common stock in connection with the forward sale agreement described below for gross proceeds of approximately $677 million before underwriting discounts and estimated offering expenses payable by the Company. The shares will be offered from time to time in one or more transactions on the New York Stock Exchange, in the over-th.
Neutral
Business Wire
1 month ago
Ventas Announces Underwritten Offering of 10.6 Million Shares of Common Stock
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it is commencing an underwritten public offering of 10,600,000 shares of its common stock in connection with the forward sale agreement described below. Ventas intends to grant the underwriter a 30-day option to purchase up to an additional 1,590,000 shares of its common stock. If such option is exercised, then Ventas plans to enter into an additional forward sale agreement with the forward purch.
Charts implemented using Lightweight Charts™